Anzeige
Mehr »
Login
Dienstag, 19.01.2021 Börsentäglich über 12.000 News von 656 internationalen Medien
Clarity hebt ab: Massenweise sichtbares Gold (25%), Rekordvolumen und Allzeithoch!
Anzeige

Indizes

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Aktien

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Xetra-Orderbuch

Devisen

Kurs

%

Rohstoffe

Kurs

%

Themen

Kurs

%

Erweiterte Suche

WKN: A14XC6 ISIN: US63016Q1022 Ticker-Symbol: 26C 
Tradegate
19.01.21
21:08 Uhr
15,030 Euro
+0,700
+4,88 %
1-Jahres-Chart
NANTKWEST INC Chart 1 Jahr
5-Tage-Chart
NANTKWEST INC 5-Tage-Chart
RealtimeGeldBriefZeit
14,79015,23022:15
14,81015,42022:00

Aktuelle News zur NANTKWEST Aktie

  • Alle
  • Pressemitteilungen
  • Empfehlungen
  • Chartanalysen
  • Berichte
ZeitAktuelle Nachrichten
Sprache: Alle DE EN
LeserMedien
NANTKWEST Aktie jetzt für 0€ handeln
17:10NantKwest/ImmunityBio's COVID-19 vaccine candidate on go with early stage-study in South Africa3
FrNantKwest: Taking A Deeper Dive Into Their COVID-19 Vaccine Efforts As Deaths Spike And New Variants Evolve9
DoLexicon Pharmaceuticals and NantKwest among healthcare gainers; Cassava Sciences among losers42
DoNantKwest is up in pre-market as Piper Sandler remains bullish on stock15
DoHotStocks USA: +33% bei NANTKWEST, -7% bei FUELCELL ENERGY62
DoThe Daily Biotech Pulse: Alexion Pauses COVID-19 Study, NantKwest Readout, Organogenesis Jumps On Guidance, Trial Updates4
DoNantKwest Reports Positive Interim Data In Pancreatic Cancer Trials, Stock Soars12
DoNantKwest rises on positive interim data in metastatic pancreatic cancer trials31
MiNantKwest, Inc. - 8-K, Current Report7
22.12.20NantKwest Stock Goes North, QURE's HOPE-B Trial On Hold, EU Greenlights First COVID-19 Vaccine311NEW YORK CITY (dpa-AFX) - Today's Daily Dose brings you news about NantKwest's non-muscle invasive bladder cancer trial results and the company's proposed merger with privately-held ImmunityBio...
► Artikel lesen
21.12.20Why NantKwest Is Jumping Today51
21.12.202 Nants become one as Soon-Shiong combines NantKwest, ImmunityBio18
21.12.20Patrick Soon-Shiong merges troubled 'moon shot' NantKwest and cell therapy play ImmunityBio in late-stage expansion14
21.12.20NantKwest, Inc. - 8-K, Current Report5
21.12.20ImmunityBio, NantKwest To Merge In All-stock Transaction11
21.12.20NantKwest (NK) soars 61% on ImmunityBio achieving primary endpoint in bladder cancer study with 72% complete response17
21.12.20NantKwest rises 21% on ImmunityBio merger deal8
11.12.20NantKwest and vTv Therapeutics among healthcare gainers; SELLAS Life Sciences and Nabriva Therapeutics among losers26
11.12.20NantKwest gains 16% on COVID-19 vaccine data in monkeys21
11.11.20ImmunityBio, NantKwest announce positive interim phase 1 safety data of hAd5 Covid-19 vaccine dose study26
Seite:  Weiter >>
34 Nachrichten in den letzten 12 Monaten
Ich würde die Aktie auf Sicht von 6 Monaten
VerkaufenHaltenKaufen
■ Verkaufen
■ Halten
■ Kaufen
1,1,2